Osteoporosis, Postmenopausal
156
12
19
109
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
27 trials with published results (17%)
Research Maturity
109 completed trials (70% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
3.2%
5 terminated out of 156 trials
95.6%
+9.1% vs benchmark
40%
62 trials in Phase 3/4
25%
27 of 109 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 109 completed trials
Clinical Trials (156)
High-Intensity Laser Therapy and Physiotherapy for Bone Health in Postmenopausal Women: A Randomized Trial
Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease
Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)
Sequential Therapies After Osteoanabolic Treatment
Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients
Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes
Combined Anabolic Therapy
The Effect of the Probiotic Strains on Bone Mineral Density in Postmenopausal Women
Romosozumab Use to Build Skeletal Integrity
Mechanisms of Anabolic Osteoporosis Therapy
Telerehabilitation Versus Traditional Balance Training in Women With Osteoporosis.
Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship
Effect of Mechanical Loading With PTH on Cortical Bone
Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis
Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)
Evaluation of a Decision Analysis Model in the DASH-Osteo Decision Aid.
Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge
Effect of GLP-1 Receptor Agonists on Trabecular Bone Score